Wednesday 14 June 2017

Commentary: Current Status and Future of Corneal Xenotransplantation

Corneal Xenotransplantation
Corneal transplantation is the treatment of choice for late stage of corneal decompensation.

According to “Cost-benefit analysis of corneal transplant”, which has been prepared by Eye Bank Association of America (EBAA) and reported by the Lewin group in 2013, net lifetime benefit from the transplantation is $118,000, while, the medical cost of the transplant is $16,500.

However, corneal donation does not meet the demand for corneal transplantation in developing countries and the number of the eligible cornea will be reduced in the future aged societies of the developed countries

No comments:

Post a Comment